Streetbeat News

SNANF

Sona Nanotech Inc.

Industry

Dimension Stone Mining and Quarrying

Open

0.18

Mkt cap

20M

Volume

High

0.19

P/E Ratio

-9.65

52-wk high

0.41

Low

0.18

Div yield

N/A

52-wk low

0.15

Sona Nanotech Inc. has announced strong efficacy results from its third preclinical study of its Targeted Hyperthermia Therapy (THT) using gold nanorods for treating solid cancer tumors. The study focused on colorectal cancer, showing promising results and plans for a first-in-human feasibility study.

Portfolio Pulse from

December 11, 2024 | 2:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.